- Ribavirin has two FDA “black box” warnings :
Use before or during pregnancy by either sex may result in birth defects in the baby.
Risk of red blood cell breakdown.
- Ribavirin should not be given with Zidovudine (AZT) because of the increased risk of Anemia
- Ribavirin should not be given with Didanosine because of the increased risk of Mitochondrial toxicity
Please refer to the manufacturer’s website to learn all the information needed to use this medicine safely and effectively